New trial pits two drug combos against Tough-to-Treat lymphoma return
NCT ID NCT07389356
Summary
This study aims to find out which of two different chemotherapy combinations works better for people whose diffuse large B-cell lymphoma has come back more than a year after initial treatment. About 70 participants will be randomly assigned to receive one of the two drug regimens over four treatment cycles. Doctors will closely track how well the cancer responds and monitor side effects to determine the better option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DLBCL - DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.